Epstein Secrets

slative priorities." Nessel added, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post <https://www.washingtonpost.coin/opinions/boies-olson-lawyers-bush-gore-2000-joe- biden-president/2020/11/14/1e113520-25ff-Il

<https://www.washingtontimes.corn/news/2020/nov/15/biden-adviser-ron-klain-trump-stonewalling-harming/> EFTA00137221 (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key officia

n made after the election as the Biden team continues to wait for access government officials and resources to begin the formal transition process." Klain said, "There's a lot of things that are going to have to wait until Joe Biden is president, but this is not one of them.... This is a national cris

lative priorities." Nessel added, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post (11/14, 14.2M) op-ed, David Boies, chairman of Boies, Schiller & Flexner, and Theodore B. Olson, a partner at Gibson, Dunn &

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

lative priorities." Nessel added, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post (11/14, 14.2M) op-ed, David Boies, chairman of Boies, Schiller & Flexner, and Theodore B. Olson, a partner at Gibson, Dunn &

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

lative priorities." Nessel added, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post (11/14, 14.2M) op-ed, David Boies, chairman of Boies, Schiller & Flexner, and Theodore B. Olson, a partner at Gibson, Dunn &

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici